What Researchers Did
Researchers investigated hyperbaric oxygen therapy (HBOT) in two patients with cyclophosphamide-induced hemorrhagic cystitis that did not respond to conventional management.
What They Found
Both patients, who received 19 and 36 sessions of HBOT respectively, experienced complete cessation of bleeding with no reported side effects. Furthermore, there was no relapse of hemorrhagic cystitis observed after 12 months following treatment cessation.
What This Means for Canadian Patients
Canadian patients suffering from cyclophosphamide-induced hemorrhagic cystitis might benefit from hyperbaric oxygen therapy as a safe and effective alternative treatment. This approach could offer a new option when conventional management proves unsatisfactory.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in India.
Study Limitations
A significant limitation of this study is its very small sample size, consisting of only two case reports.